Talk:Ceftolozane/tazobactam
Appearance
This is the talk page for discussing improvements to the Ceftolozane/tazobactam article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ceftolozane/tazobactam.
|
out of date
[edit]Please, update this article. it was approved in december with the brand name 'Zerbaxa'. here's the FDA announcement: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427534.htm — Preceding unsigned comment added by 198.49.6.225 (talk) 10:36, 2 June 2015 (UTC)
- Ceftolozane is not Zerbaxa at all. Zerbaxa is a combination of ceftolozane and tazobactam! — Preceding unsigned comment added by 134.176.242.3 (talk) 11:35, 22 April 2016 (UTC)
Categories:
- Start-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles
- Start-Class medicine articles
- Mid-importance medicine articles
- All WikiProject Medicine pages
- Stub-Class articles with conflicting quality ratings
- Stub-Class chemicals articles
- Low-importance chemicals articles